An innovative therapeutic antibody gene transfer platform

Monoclonal antibodies are taking the field of cancer and immunotherapy by storm, but limitations in terms of pharmaco-economics, -kinetics & efficacy remain. Our DNA approach addresses these issues by turning the patient into the medicine producer.